{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:00:09Z","timestamp":1773673209472,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12325-018-0776-z","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T13:51:42Z","timestamp":1535809902000},"page":"1510-1518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Current and Emerging Treatment Modalities for Leber\u2019s Hereditary Optic Neuropathy: A Review of the Literature"],"prefix":"10.1007","volume":"35","author":[{"given":"Anna","family":"Theodorou-Kanakari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Karampitianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Karageorgou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Kampourelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathios","family":"Kapasakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Theodossiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Chatziralli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"776_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/164_2016_1","volume":"240","author":"R Bi","year":"2017","unstructured":"Bi R, Logan I, Yao YG. Leber hereditary optic neuropathy: a mitochondrial disease unique in many ways. Handb Exp Pharmacol. 2017;240:309\u201336.","journal-title":"Handb Exp Pharmacol"},{"key":"776_CR2","first-page":"927","volume":"16","author":"J Jancic","year":"2017","unstructured":"Jancic J, Samardzic J, Stojanovic S, Stojanovic A, Milanovic AM, Nikolic B, Ivancevic N, Kostic V. Leber\u2019s hereditary optic neuropathy: novel views and persisting challenges. CNS Neurol Disord Drug Targets. 2017;16:927\u201335.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"776_CR3","first-page":"51","volume":"8","author":"Y Dai","year":"2018","unstructured":"Dai Y, Wang C, Nie Z, Han J, Chen T, Zhao X, Ai C, Ji Y, Gao T, Jiang P. Mutation analysis of Leber\u2019s hereditary optic neuropathy using a multi-gene panel. Biomed Rep. 2018;8:51\u20138.","journal-title":"Biomed Rep"},{"key":"776_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/OPX.0000000000001147","volume":"94","author":"Q Lu","year":"2017","unstructured":"Lu Q, Guo Y, Yi J, Deng X, Yang Z, Yuan X, Deng H. Identification of an ND4 mutation in leber hereditary optic neuropathy. Optom Vis Sci. 2017;94:1090\u20134.","journal-title":"Optom Vis Sci"},{"key":"776_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/164_2017_2","volume":"240","author":"DC Wallace","year":"2017","unstructured":"Wallace DC, Lott MT. Leber hereditary optic neuropathy: exemplar of an mtDNA disease. Handb Exp Pharmacol. 2017;240:339\u201376.","journal-title":"Handb Exp Pharmacol"},{"key":"776_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-014-0158-9","volume":"9","author":"K Dimitriadis","year":"2014","unstructured":"Dimitriadis K, Leonhardt M, Yu-Wai-Man P, Kirkman MA, Korsten A, De Coo IF, Chinnery PF, Klopstock T. Leber\u2019s hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients. Orphanet J Rare Dis. 2014;9:158.","journal-title":"Orphanet J Rare Dis"},{"key":"776_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/WNO.0000000000000598","volume":"38","author":"\u00d8K J\u00f8rstad","year":"2018","unstructured":"J\u00f8rstad \u00d8K, \u00d8degaard EM, Heimdal KR, Kerty E, Heimdal KR, Kerty E. Leber hereditary optic neuropathy caused by a mitochondrial DNA 10663T>C point mutation and its response to idebenone treatment. J Neuroophthalmol. 2018;38:129\u201331.","journal-title":"J Neuroophthalmol"},{"key":"776_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mito.2017.07.006","volume":"36","author":"A Majander","year":"2017","unstructured":"Majander A, Robson AG, Jo\u00e3o C, Holder GE, Chinnery PF, Moore AT, Votruba M, Stockman A, Yu-Wai-Man P. The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy. Mitochondrion. 2017;36:138\u201349.","journal-title":"Mitochondrion"},{"key":"776_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cxo.12634","volume":"101","author":"J Gonz\u00e1lez-Mart\u00edn-Moro","year":"2018","unstructured":"Gonz\u00e1lez-Mart\u00edn-Moro J, Castro-Rebollo M, Contreras I, P\u00e9rez-Sarriegui A. Subclinical thinning of macular ganglion cell layer in Leber optic neuropathy carriers. Clin Exp Optom. 2018;101:406\u201311. https:\/\/doi.org\/10.1111\/cxo.12634.","journal-title":"Clin Exp Optom"},{"key":"776_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.freeradbiomed.2015.05.039","volume":"88","author":"G Hayashi","year":"2015","unstructured":"Hayashi G, Cortopassi G. Oxidative stress in inherited mitochondrial diseases. Free Radic Biol Med. 2015;88:10\u20137.","journal-title":"Free Radic Biol Med"},{"key":"776_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"P Yu-Wai-Man","year":"2003","unstructured":"Yu-Wai-Man P, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72:333\u20139.","journal-title":"Am J Hum Genet"},{"key":"776_CR12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1167\/iovs.15-18306","volume":"57","author":"T Rosenberg","year":"2016","unstructured":"Rosenberg T, N\u00f8rby S, Schwartz M, Saillard J, Magalh\u00e3es PJ, Leroy D, Kann EC, Duno M. Prevalence and genetics of Leber hereditary optic neuropathy in the Danish population. Invest Ophthalmol Vis Sci. 2016;57:1370\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"776_CR13","first-page":"1165","volume":"9","author":"C Meyerson","year":"2015","unstructured":"Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol. 2015;9:1165\u201376.","journal-title":"Clin Ophthalmol"},{"key":"776_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/aos.12515","volume":"93","author":"A Grzybowski","year":"2015","unstructured":"Grzybowski A, Z\u00fclsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93:402\u201310.","journal-title":"Acta Ophthalmol"},{"key":"776_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.spen.2017.06.001","volume":"24","author":"BY Chun","year":"2017","unstructured":"Chun BY, Rizzo JF 3rd. Dominant optic atrophy and Leber\u2019s hereditary optic neuropathy: update on clinical features and current therapeutic approaches. Semin Pediatr Neurol. 2017;24:129\u201334.","journal-title":"Semin Pediatr Neurol"},{"key":"776_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/wno.0000000000000623","author":"C Orssaud","year":"2018","unstructured":"Orssaud C. Cardiac disorders in patients with Leber hereditary optic neuropathy. J Neuroophthalmol. 2018. https:\/\/doi.org\/10.1097\/wno.0000000000000623 (in press).","journal-title":"J Neuroophthalmol"},{"key":"776_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1055\/s-0035-1563574","volume":"35","author":"P Yu-Wai-Man","year":"2015","unstructured":"Yu-Wai-Man P. Therapeutic approaches to inherited optic neuropathies. Semin Neurol. 2015;35:578\u201386.","journal-title":"Semin Neurol"},{"key":"776_CR18","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1167\/iovs.08-3166","volume":"50","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P. Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:3112\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"776_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archopht.1993.01090040087038","volume":"111","author":"DR Johns","year":"1993","unstructured":"Johns DR, Heher KL, Miller NR, Smith KH. Leber\u2019s hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol. 1993;111:495\u20138.","journal-title":"Arch Ophthalmol"},{"key":"776_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/eye.2014.37","volume":"28","author":"P Yu-Wai-Man","year":"2014","unstructured":"Yu-Wai-Man P, Votruba M, Moore AT, Chinnery PF. Treatment strategies for inherited optic neuropathies: past, present and future. Eye. 2014;28:521\u201337.","journal-title":"Eye"},{"key":"776_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/ICU.0000000000000212","volume":"26","author":"JH Peragallo","year":"2015","unstructured":"Peragallo JH, Newman NJ. Is there treatment for Leber hereditary optic neuropathy? Curr Opin Ophthalmol. 2015;26:450\u20137.","journal-title":"Curr Opin Ophthalmol"},{"key":"776_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4103\/ijo.IJO_358_17","volume":"65","author":"AH Manickam","year":"2017","unstructured":"Manickam AH, Michael MJ, Ramasamy S. Mitochondrial genetics and therapeutic overview of Leber\u2019s hereditary optic neuropathy. Indian J Ophthalmol. 2017;65:1087\u201392.","journal-title":"Indian J Ophthalmol"},{"key":"776_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/1381612823666170125164856","volume":"23","author":"R Karanjia","year":"2017","unstructured":"Karanjia R, Chahal J, Ammar M, Sadun AA. Treatment of Leber\u2019s hereditary optic neuropathy. Curr Pharm Des. 2017;23:624\u20138.","journal-title":"Curr Pharm Des"},{"key":"776_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","volume":"26","author":"G Le Meur","year":"2018","unstructured":"Le Meur G, Lebranchu P, Billaud F, Adjali O, Schmitt S, B\u00e9zieau S, P\u00e9r\u00e9on Y, Valabregue R, Ivan C, Darmon C, Moullier P, Rolling F, Weber M. Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 Leber congenital amaurosis. Mol Ther. 2018;26:256\u201368.","journal-title":"Mol Ther"},{"key":"776_CR25","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/brain\/awr192","volume":"134","author":"NJ Newman","year":"2011","unstructured":"Newman NJ. Treatment of Leber hereditary optic neuropathy. Brain. 2011;134:2447\u201350.","journal-title":"Brain"},{"key":"776_CR26","first-page":"141","volume":"15","author":"S Iyer","year":"2013","unstructured":"Iyer S. Novel therapeutic approaches for Leber\u2019s hereditary optic neuropathy. Discov Med. 2013;15:141\u20139.","journal-title":"Discov Med"},{"key":"776_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","volume":"137","author":"C Giordano","year":"2014","unstructured":"Giordano C, Iommarini L, Giordano L, Maresca A, Pisano A, Valentino ML, Caporali L, Liguori R, Deceglie S, Roberti M, Fanelli F, Fracasso F, Ross-Cisneros FN, D\u2019Adamo P, Hudson G, Pyle A, Yu-Wai-Man P, Chinnery PF, Zeviani M, Salomao SR, Berezovsky A, Belfort R Jr, Ventura DF, Moraes M, Moraes Filho M, Barboni P, Sadun F, De Negri A, Sadun AA, Tancredi A, Mancini M, d\u2019Amati G, Loguercio Polosa P, Cantatore P, Carelli V. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy. Brain. 2014;137:335\u201353.","journal-title":"Brain"},{"key":"776_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ddrr.109","volume":"16","author":"T Wenz","year":"2010","unstructured":"Wenz T, Williams SL, Bacman SR, Moraes CT. Emerging therapeutic approaches to mitochondrial diseases. Dev Disabil Res Rev. 2010;16:219\u201329.","journal-title":"Dev Disabil Res Rev"},{"key":"776_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fneur.2014.00141","volume":"5","author":"C La Morgia","year":"2014","unstructured":"La Morgia C, Carbonelli M, Barboni P, Sadun AA, Carelli V. Medical management of hereditary optic neuropathies. Front Neurol. 2014;5:141.","journal-title":"Front Neurol"},{"key":"776_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archophthalmol.2009.9","volume":"127","author":"M Saylor","year":"2009","unstructured":"Saylor M, McLoon LK, Harrison AR, Lee MS. Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent. Arch Ophthalmol. 2009;127:402\u20136.","journal-title":"Arch Ophthalmol"},{"key":"776_CR31","first-page":"407","volume":"140","author":"NJ Newman","year":"2005","unstructured":"Newman NJ, Biousse V, David R, Bhatti MT, Hamilton SR, Farris BK, Lesser RL, Newman SA, Turbin RE, Chen K, Keaney RP. Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol. 2005;140:407\u201315.","journal-title":"Am J Ophthalmol"},{"key":"776_CR32","doi-asserted-by":"publisher","first-page":"e63446","DOI":"10.1371\/journal.pone.0063446","volume":"8","author":"A Thouin","year":"2013","unstructured":"Thouin A, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P. Raised intraocular pressure as a potential risk factor for visual loss in Leber hereditary optic neuropathy. PLoS ONE. 2013;8:e63446.","journal-title":"PLoS ONE"},{"key":"776_CR33","first-page":"6921","volume":"24","author":"A Pisano","year":"2015","unstructured":"Pisano A, Preziuso C, Iommarini L, Perli E, Grazioli P, Campese AF, Maresca A, Montopoli M, Masuelli L, Sadun AA, d\u2019Amati G, Carelli V, Ghelli A, Giordano C. Targeting estrogen receptor \u03b2 as preventive therapeutic strategy for Leber\u2019s hereditary optic neuropathy. Hum Mol Genet. 2015;24:6921\u201331.","journal-title":"Hum Mol Genet"},{"key":"776_CR34","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1074\/jbc.M807321200","volume":"284","author":"AM Porcelli","year":"2009","unstructured":"Porcelli AM, Angelin A, Ghelli A, Mariani E, Martinuzzi A, Carelli V, Petronilli V, Bernardi P, Rugolo M. Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels. J Biol Chem. 2009;284:2045\u201352.","journal-title":"J Biol Chem"},{"key":"776_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/pho.2006.24.121","volume":"24","author":"KD Desmet","year":"2006","unstructured":"Desmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS, Yeager RL, Millsap DS, Lim J, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, Whelan HT. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg. 2006;24:121\u20138.","journal-title":"Photomed Laser Surg"},{"key":"776_CR36","first-page":"130","volume":"2","author":"N Gueven","year":"2013","unstructured":"Gueven N, Faldu D. Therapeutic strategies for Leber\u2019s hereditary optic neuropathy: a current update. Intractable Rare Dis Res. 2013;2:130\u20135.","journal-title":"Intractable Rare Dis Res"},{"key":"776_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","volume":"47","author":"S Jaber","year":"2015","unstructured":"Jaber S, Polster BM. Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr. 2015;47:111\u20138.","journal-title":"J Bioenerg Biomembr"},{"key":"776_CR38","doi-asserted-by":"publisher","first-page":"e45182","DOI":"10.1371\/journal.pone.0045182","volume":"7","author":"FD Heitz","year":"2012","unstructured":"Heitz FD, Erb M, Anklin C, et al. Idebenone protects against retinal damage and loss of vision in a mouse mode of Leber\u2019s hereditary optic neuropathy. PLoS ONE. 2012;7:e45182.","journal-title":"PLoS ONE"},{"key":"776_CR39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","volume":"340","author":"Y Mashima","year":"1992","unstructured":"Mashima Y, Hiida Y, Oguchi Y. Remission of Leber\u2019s hereditary optic neuropathy with idebenone. Lancet. 1992;340:368\u20139.","journal-title":"Lancet"},{"key":"776_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0022-510X(98)00239-1","volume":"160","author":"V Carelli","year":"1998","unstructured":"Carelli V, Barboni P, Zacchini A, Mancini R, Monari L, Cevoli S, Liguori R, Sensi M, Lugaresi E, Montagna P. Leber\u2019s hereditary optic neuropathy (LHON) with 14484\/ND6 mutation in a North African patient. J Neurol Sci. 1998;160:183\u20138.","journal-title":"J Neurol Sci"},{"key":"776_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0022-510X(96)00311-5","volume":"148","author":"P Cortelli","year":"1997","unstructured":"Cortelli P, Montagna P, Pierangeli G, Lodi R, Barboni P, Liguori R, Carelli V, Iotti S, Zaniol P, Lugaresi E, Barbiroli B. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber\u2019s hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci. 1997;148:25\u201331.","journal-title":"J Neurol Sci"},{"key":"776_CR42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","volume":"20","author":"Y Mashima","year":"2000","unstructured":"Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuroophthalmol. 2000;20:166\u201370.","journal-title":"J Neuroophthalmol"},{"key":"776_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4321\/S0365-66912007000600012","volume":"82","author":"N Barnils","year":"2007","unstructured":"Barnils N, Mesa E, Mu\u00f1oz S, Ferrer-Artola A, Arruga J. Response to idebenone and multivitamin therapy in Leber\u2019s hereditary optic neuropathy. Arch Soc Esp Oftalmol. 2007;82:377\u201380.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"776_CR44","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/brain\/awr180","volume":"134","author":"V Carelli","year":"2011","unstructured":"Carelli V, La Morgia C, Valentino ML, Rizzo G, Carbonelli M, De Negri AM, Sadun F, Carta A, Guerriero S, Simonelli F, Sadun AA, Aggarwal D, Liguori R, Avoni P, Baruzzi A, Zeviani M, Montagna P, Barboni P. Idebenone treatment in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134:e18.","journal-title":"Brain"},{"key":"776_CR45","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, Atawan A, Chattopadhyay S, Schubert M, Garip A, Kernt M, Petraki D, Rummey C, Leinonen M, Metz G, Griffiths PG, Meier T, Chinnery PF. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134:2677\u201386.","journal-title":"Brain"},{"key":"776_CR46","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1093\/brain\/aws279","volume":"136","author":"T Klopstock","year":"2013","unstructured":"Klopstock T, Metz G, Yu-Wai-Man P, B\u00fcchner B, Gallenm\u00fcller C, Bailie M, Nwali N, Griffiths PG, von Livonius B, Reznicek L, Rouleau J, Coppard N, Meier T, Chinnery PF. Persistence of the treatment effect of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2013;136:e230.","journal-title":"Brain"},{"key":"776_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/WNO.0b013e318272c643","volume":"33","author":"G Rudolph","year":"2013","unstructured":"Rudolph G, Dimitriadis K, B\u00fcchner B, Heck S, Al-Tamami J, Seidensticker F, Rummey C, Leinonen M, Meier T, Klopstock T. Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy. J Neuroophthalmol. 2013;33:30\u20136.","journal-title":"J Neuroophthalmol"},{"key":"776_CR48","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","volume":"37","author":"V Carelli","year":"2017","unstructured":"Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagr\u00e8ze WA, La Morgia C, Newman NJ, Orssaud C, Pott JWR, Sadun AA, van Everdingen J, Vignal-Clermont C, Votruba M, Yu-Wai-Man P, Barboni P. International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuroophthalmol. 2017;37:371\u201381.","journal-title":"J Neuroophthalmol"},{"key":"776_CR49","first-page":"141","volume":"15","author":"S Iyer","year":"2013","unstructured":"Iyer S. Novel therapeutic approaches for Leber\u2019s hereditary optic neuropathy. Discov Med. 2013;15:141\u20139.","journal-title":"Discov Med"},{"key":"776_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","volume":"69","author":"AA Sadun","year":"2012","unstructured":"Sadun AA, Chicani CF, Ross-Cisneros FN, Barboni P, Thoolen M, Shrader WD, Kubis K, Carelli V, Miller G. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol. 2012;69:331\u20138.","journal-title":"Arch Neurol"},{"key":"776_CR51","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1055\/s-0035-1563574","volume":"35","author":"P Yu-Wai-Man","year":"2015","unstructured":"Yu-Wai-Man P. Therapeutic approaches to inherited optic neuropathies. Semin Neurol. 2015;35:578\u201386.","journal-title":"Semin Neurol"},{"key":"776_CR52","first-page":"517","volume":"140","author":"NJ Newman","year":"2005","unstructured":"Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol. 2005;140:517\u201323.","journal-title":"Am J Ophthalmol"},{"key":"776_CR53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ana.10354","volume":"52","author":"J Guy","year":"2002","unstructured":"Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW, Lewin AS. Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann Neurol. 2002;52:534\u201342.","journal-title":"Ann Neurol"},{"key":"776_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamaophthalmol.2013.7630","volume":"132","author":"RD Koilkonda","year":"2014","unstructured":"Koilkonda RD, Yu H, Chou TH, Feuer WJ, Ruggeri M, Porciatti V, Tse D, Hauswirth WW, Chiodo V, Boye SL, Lewin AS, Neuringer M, Renner L, Guy J. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Ophthalmol. 2014;132:409\u201320.","journal-title":"JAMA Ophthalmol"},{"key":"776_CR55","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/mtm.2015.3","volume":"2","author":"H Cwerman-Thibault","year":"2015","unstructured":"Cwerman-Thibault H, Augustin S, Lechauve C, Ayache J, Ellouze S, Sahel JA, Corral-Debrinski M. Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss. Mol Ther Methods Clin Dev. 2015;2:15003.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"776_CR56","doi-asserted-by":"publisher","first-page":"21587","DOI":"10.1038\/srep21587","volume":"6","author":"X Wan","year":"2016","unstructured":"Wan X, Pei H, Zhao MJ, Yang S, Hu WK, He H, Ma SQ, Zhang G, Dong XY, Chen C, Wang DW, Li B. Efficacy and safety of rAAV2-ND4 treatment for Leber\u2019s hereditary optic neuropathy. Sci Rep. 2016;6:21587.","journal-title":"Sci Rep"},{"key":"776_CR57","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","volume":"124","author":"J Guy","year":"2017","unstructured":"Guy J, Feuer WJ, Davis JL, Porciatti V, Gonzalez PJ, Koilkonda RD, Yuan H, Hauswirth WW, Lam BL. Gene therapy for Leber hereditary optic neuropathy: low-and medium-dose visual results. Ophthalmology. 2017;124:1621\u201334.","journal-title":"Ophthalmology"},{"key":"776_CR58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ophtha.2017.12.036","volume":"125","author":"C Vignal","year":"2018","unstructured":"Vignal C, Uretsky S, Fitoussi S, Galy A, Blouin L, Girmens JF, Bidot S, Thomasson N, Bouquet C, Valero S, Meunier S, Combal JP, Gilly B, Katz B, Sahel JA. Safety of rAAV2\/2-ND4 gene therapy for Leber hereditary optic neuropathy. Ophthalmology. 2018;125:945\u201347.","journal-title":"Ophthalmology"},{"key":"776_CR59","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/ICU.0000000000000473","volume":"29","author":"A DeBusk","year":"2018","unstructured":"DeBusk A, Moster ML. Gene therapy in optic nerve disease. Curr Opin Ophthalmol. 2018;29:234\u20138.","journal-title":"Curr Opin Ophthalmol"},{"key":"776_CR60","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4103\/1673-5374.193251","volume":"11","author":"JN Weiss","year":"2016","unstructured":"Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber\u2019s hereditary optic neuropathy. Neural Regen Res. 2016;11:1685\u201394.","journal-title":"Neural Regen Res"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0776-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-018-0776-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0776-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:32:35Z","timestamp":1724412755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-018-0776-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s12325-018-0776-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}